Title:
RET GENE FUSIONS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/007015
Kind Code:
A3
Abstract:
Provided herein are rearranged during transfection (RET) fusion nucleic acid molecules and RET fusion polypeptides, methods related to detecting RET fusion nucleic acid molecules and RET fusion polypeptides in cancer, as well as methods of treatment and uses related thereto. Detection of a RET fusion nucleic acid molecule or a RET fusion polypeptide can be used to identify individuals that may benefit from treatment with an anti-cancer therapy.
Inventors:
GORNSTEIN ERICA (US)
ERBACH RACHEL (US)
LIU XIN (US)
HUANG RICHARD SHENG POE (US)
KUANG ZHENG (US)
PARIMI VAMSI (US)
ERBACH RACHEL (US)
LIU XIN (US)
HUANG RICHARD SHENG POE (US)
KUANG ZHENG (US)
PARIMI VAMSI (US)
Application Number:
PCT/US2023/069544
Publication Date:
April 11, 2024
Filing Date:
June 30, 2023
Export Citation:
Assignee:
FOUND MEDICINE INC (US)
International Classes:
C07K14/82; C12Q1/6886; G01N33/574
Attorney, Agent or Firm:
JONES, Kevin Theodore et al. (US)
Download PDF: